Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Jan-24 4:28 PM View:  | Apellis Pharmaceuticals, Inc. (APLS) | 30-Jan-24 | Sale (Planned) | 883 | $65.53 | $57,863.00 | (2%) 47.27K to 46.39K | |
| 31-Jan-24 4:28 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 29-Jan-24 | Private Sale | 367 | $64.14 | $23,538.70 | (< 1%) 47.64K to 47.27K | |
| 24-Jan-24 4:06 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Jan-24 | Private Sale (Planned) | 4,286 | $63.69 | $272,975.00 | (8%) 51.92K to 47.64K | |
| 23-Jan-24 6:07 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 22-Jan-24 | Private Sale | 1,738 | $65.00 | $112,963.00 | (3%) 53.66K to 51.92K | |
| 18-Jan-24 4:54 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 17-Jan-24 | Private Sale (Planned) | 3,276 | $65.58 | $214,840.00 | (6%) 56.94K to 53.66K | |
| 17-Jan-24 4:43 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Grant | 16,963 | -- | -- | 41% 41.61K to 58.57K | |
| 17-Jan-24 4:43 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 16-Jan-24 | Sale | 1,632 | $66.81 | $109,032.00 | (3%) 58.57K to 56.94K | |
| 02-Jun-23 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Jun-23 | Option Exercise | 5,000 | $34.11 | $170,550.00 | 12% 41.5K to 46.5K | |
| 02-Jun-23 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 01-Jun-23 | Planned Option Sale | 5,000 | $86.00 | $430,000.00 | (11%) 46.5K to 41.5K | |
| 05-Apr-23 4:52 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Apr-23 | Option Exercise | 5,000 | $34.11 | $170,550.00 | 12% 41.43K to 46.43K | |
| 05-Apr-23 4:52 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 03-Apr-23 | Planned Option Sale | 5,000 | $75.00 | $375,000.00 | (11%) 46.43K to 41.43K | |
| 27-Feb-23 4:32 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Feb-23 | Private Sale (Planned) | 1,104 | $68.76 | $75,911.00 | (3%) 42.53K to 41.43K | |
| 22-Feb-23 6:50 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Grant | 6,628 | -- | -- | 18% 36.46K to 43.09K | |
| 22-Feb-23 6:50 AM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Feb-23 | Payment of Exercise | 553 | $58.50 | $32,350.50 | (1%) 43.09K to 42.53K | |
| 31-Jan-23 4:47 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 30-Jan-23 | Private Sale (Planned) | 883 | $52.76 | $46,587.10 | (2%) 37.34K to 36.46K | |
| 30-Jan-23 5:01 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 27-Jan-23 | Payment of Exercise | 367 | $52.77 | $19,366.60 | (< 1%) 37.71K to 37.34K | |
| 25-Jan-23 4:17 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 23-Jan-23 | Private Sale (Planned) | 2,955 | $51.58 | $152,419.00 | (7%) 40.66K to 37.71K | |
| 24-Jan-23 5:20 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 20-Jan-23 | Payment of Exercise | 1,411 | $52.05 | $73,442.50 | (3%) 42.08K to 40.66K | |
| 17-Jan-23 7:39 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 12-Jan-23 | Grant | 19,634 | -- | -- | 87% 22.44K to 42.08K | |
| 17-Jan-23 7:39 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 25-Apr-22 | Disposition (other) | 1,250 | -- | -- | (5%) 23.47K to 22.22K | |
| 01-Feb-22 5:59 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-22 | Payment of Exercise | 434 | $38.59 | $16,748.10 | (2%) 23.91K to 23.47K | (15%) |
| 25-Jan-22 4:40 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 21-Jan-22 | Grant | 17,466 | -- | -- | 271% 6.44K to 23.91K | |
| 01-Feb-21 4:37 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 28-Jan-21 | Grant | 6,250 | -- | -- | 100% 0 to 6.25K |